Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series (CCHD)
Primary Purpose
Chronic Cluster Headache
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Atkins diet
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Cluster Headache focused on measuring Ketogenic Diet
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of CCH (less than 30 consecutive days of attacks remission in the last year)
- kept a headache diary for at least 1 month
- CH onset before the age of 50
Exclusion Criteria:
- over consumption of acute pain-killers (triptan, analgesic, or ergotamine)
- pregnancy or lactation
- type I diabetes
- serious organic or psychiatric disorders that the investigators judged as having the potential to influence the trial evaluation.
Sites / Locations
- Policlinico Umberto I
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Modified Atkins Diet (MAD)
Arm Description
CCH patients that follows at least 3 months of MAD
Outcomes
Primary Outcome Measures
Attack frequency
Reduction of at least 50% of number of attacks per month
Secondary Outcome Measures
Full Information
NCT ID
NCT03244735
First Posted
August 5, 2017
Last Updated
August 10, 2017
Sponsor
University of Roma La Sapienza
1. Study Identification
Unique Protocol Identification Number
NCT03244735
Brief Title
Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series
Acronym
CCHD
Official Title
Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache. A Prospective Case Series
Study Type
Interventional
2. Study Status
Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
August 2017 (Actual)
Study Completion Date
August 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Roma La Sapienza
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Atkins diet is a nutritional regimen characterized by ad libitum protein and fat intake, but carbohydrate restriction. It is followed by millions of people around the word as a life-style, but in the last years was proposed as a treatment for the epilepsy, by its capacity to induce the state of ketosis.
Since Authors observed that ketosis could be also useful in migraine, and migraine shares some pathophysiological features with cluster headache, The aim of the study is to test the efficacy of Atkins diet in Cluster Headache by an open label one harm observational study.
Detailed Description
The Atkins diet is a ketogenic high-fat, low-carbohydrate diet for long adopted as lifestyle by people that dislike have an high carbohydrate intake. This nutritional life style seems to account for more energy in the daily activity and an easy weight control. In the last years, researchers showed that a modified Atkins diet (MAD) can be useful to treat drug resistant epilepsy, maybe by the induction of ketogenesis.
Ketogenesis, ketone-body formation, is a physiologic phenomenon also observed in patients following low-carbohydrate high fat diets. Different Authors evidenced a protective effect of ketone bodies also on migraine that shares some pathophysiological features with cluster headache (CH).
CH is the worst form of headache, also called as "suicide headache"; in particular its unremitting form, called Chronic CH (CCH) is regarded as a clinical challenge for neurologist, if refractory to pharmacological treatments. So far, no data are available about a beneficial effect of ketogenesis in CH. However, the beta hydroxybutyrate (BHB) has a chemical formula similar to gamma hydroxybutyrate (GHB) that has shown to be effective in CH. Moreover, ketosis has also a beneficial effect on hypothalamic dysfunctions that are shared by some form of epilepsy and CH.
Aim of this study is verify in an open label observational study if a MAD can be useful in the treatment of CCH. In case of positive outcome, the results could be used as preliminary data to design a double blind versus placebo study, to asses definitively if ketogenesis is really able to prevent/avoid headache attacks in CH.
Methods: By the Italian branch of the Organization for the Understanding of Cluster Headache (OUCH), there will be recruited CCH volunteers that accept to modify their diet according to Atkins Diet for at least three months.
Headache attack frequency will be collected on specific headache-calendars and a comparison between the pre-diet phase and the during-the-diet- phase will be performed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Cluster Headache
Keywords
Ketogenic Diet
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Case series
Masking
None (Open Label)
Allocation
N/A
Enrollment
18 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Modified Atkins Diet (MAD)
Arm Type
Experimental
Arm Description
CCH patients that follows at least 3 months of MAD
Intervention Type
Other
Intervention Name(s)
Atkins diet
Intervention Description
A nutritional regimen characterized by high fat low carbohydrate intake.
Primary Outcome Measure Information:
Title
Attack frequency
Description
Reduction of at least 50% of number of attacks per month
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Diagnosis of CCH (less than 30 consecutive days of attacks remission in the last year)
kept a headache diary for at least 1 month
CH onset before the age of 50
Exclusion Criteria:
over consumption of acute pain-killers (triptan, analgesic, or ergotamine)
pregnancy or lactation
type I diabetes
serious organic or psychiatric disorders that the investigators judged as having the potential to influence the trial evaluation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Francesco Pierelli, MD
Organizational Affiliation
Sapienza Univeristy
Official's Role
Study Chair
Facility Information:
Facility Name
Policlinico Umberto I
City
Rome
ZIP/Postal Code
00161
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
We do not share data
Citations:
PubMed Identifier
28132289
Citation
Di Lorenzo C, Coppola G, Sirianni G, Rossi P, Pierelli F. O045. Cluster headache improvement during Ketogenic Diet. J Headache Pain. 2015 Dec;16(Suppl 1):A99. doi: 10.1186/1129-2377-16-S1-A99. No abstract available. Erratum In: J Headache Pain. 2017 Dec;18(1):11.
Results Reference
background
PubMed Identifier
29483892
Citation
Di Lorenzo C, Coppola G, Di Lenola D, Evangelista M, Sirianni G, Rossi P, Di Lorenzo G, Serrao M, Pierelli F. Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm, Clinical Trial. Front Neurol. 2018 Feb 12;9:64. doi: 10.3389/fneur.2018.00064. eCollection 2018.
Results Reference
derived
Learn more about this trial
Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series
We'll reach out to this number within 24 hrs